Both in Pharmaceuticals
Oruka Therapeutics vs Amneal Pharmaceuticals
Over the past year ORKA returned +269.7% and AMRX returned +75.8%; their daily moves had a correlation of 0.12.
ORKA +269.7% AMRX +75.8%Growth of $1, one year, split-adjusted
| Metric | ORKA | AMRX |
|---|---|---|
| Price | $101.41 | $19.95 |
| Market cap | $6.71B | $6.95B |
| Today | +1.87% | −1.29% |
| 1 month | +26.5% | −1.7% |
| 6 months | +45.3% | +46.5% |
| Year to date | +234.6% | +58.3% |
| 1 year | +287.2% | +78.2% |
| Revenue growth (YoY) | — | +9.9% |
| Gross margin | — | 42.0% |
| Net margin | — | 7.2% |
| P/E (TTM) | — | 44.2× |
| Price / sales | — | 2.2× |
| Net cash | $873.6M | -$2.54B |
| Dividend yield | — | — |
| Volatility (60d) | 51.8% | 38.0% |
| Short % of float | 11.5% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).